Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 10/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | PPARG | P37231 | 12/20 | 0.63 |
| ▸ | PPARD | Q03181 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | FABP2 | P12104 | 1/20 | 0.58 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.54 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7032523 | 0.98 | PPARA (0.66) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| Hydrochloric Acid SCHEMBL8889149 | 0.98 | PPARA (0.66) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| Ammonia Solution, Strong SCHEMBL7026339 | 0.98 | PPARA (0.66) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| Methylamine SCHEMBL27865949 | 0.96 | PPARA (0.63) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| Dimethylamine SCHEMBL21384551 | 0.94 | PPARA (0.61) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL7624065 | 0.92 | PPARA (0.59) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL22209208 | 0.92 | PPARG (0.74) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL9416379 | 0.88 | PPARA (0.65) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL11441192 | 0.85 | PPARG (0.76) | PPARACYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL13072375 | 0.84 | PPARA (0.50) | PPARACYP2C19MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367216-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250367217-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| EP-4602141-A1 | A FRAGRANCE MIXTURE (VI) | Symrise AG (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4532646-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-04-09 | — | — | EP | claimed |
| US-20250099349-A1 | A FRAGRANCE MIXTURE | SYMRISE AG (DE) | 2025-03-27 | — | — | US | claimed |
| EP-4519403-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-03-12 | — | — | EP | claimed |
| CN-116056706-B | Biaryl derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2024-12-27 | — | — | CN | claimed |
| EP-4472606-A1 | COMPOSITIONS (III) | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-4473079-A1 | A FRAGRANCE MIXTURE | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-0621255-B1 | Substituted phenoxy-isobutyric acids and esters | ADIR (FR) | 1997-08-20 | — | — | EP | claimed |
| US-5627205-A | ANTILIPEMIC AGENTS AND ANTIOXIDANTS | ADIR ET COMPAGNIE (FR) | 1997-05-06 | — | — | US | claimed |
| US-5512595-A | FOR SUPPRESSION OF MEMBRANE LIPID PEROXIDATION, ANTILIPEMIC AGENTS | ADIR ET COMPAGNIE (FR) | 1996-04-30 | — | — | US | claimed |
| EP-0159864-B1 | METHOD OF MODIFYING TASTE | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1989-07-19 | — | — | EP | claimed |
| EP-0159864-A2 | Method of modifying taste | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1985-10-30 | — | — | EP | claimed |
| US-4515985-A | Preparation of chlorinated phenoxyalkanoic acids | BASF AKTIENGESELLSCHAFT (DE) | 1985-05-07 | — | — | US | claimed |
| EP-0055357-B1 | PROCESS FOR THE PREPARATION OF CHLORINATED PHENOXYALKANOIC ACIDS | BASF Aktiengesellschaft (DE) | 1984-01-11 | — | — | EP | claimed |
| EP-0002151-B1 | PROCESS FOR THE SYNTHESIS OF ESTERS OF PARACHLOROBENZOYL-PHENOXY-ISOBUTYRIC ACID | LABORATOIRES FOURNIER S.A. (FR) | 1983-05-25 | — | — | EP | claimed |
| US-4372954-A | LOWERING FIBRINOGEN, ANTICOAGULANTS | MOREAU PIERRE D (FR) | 1983-02-08 | — | — | US | claimed |
| WO-1981002295-A1 | PHENOXYISOBUTYRATES OF MOROXYDIN AND DRUGS CONTAINING THEM | MOREAU P | 1981-08-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367216-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | PPARD, NR1H4, PPARG | PPARA 4/4885CYP2C19 553/4885MEN1 4532/4885 |
| US-20250099349-A1 | A FRAGRANCE MIXTURE | PTMS, EP300, TRPA1 | PPARA 64/4885CYP2C19 2956/4885MEN1 4460/4885 |
| US-20250367217-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | PPARD, NR1H4, PPARG | PPARA 4/4885CYP2C19 553/4885MEN1 4532/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | PPARA 104/4885CYP2C19 591/4885MEN1 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.